Mental and physical symptoms associated with lower social support for patients with hepatitis C

被引:49
作者
Blasiole, Julie A.
Shinkunas, Laura
LaBrecque, Douglas R.
Arnold, Robert M.
Zickmund, Susan L.
机构
[1] Univ Pittsburgh, Sch Med, VA Pittsburgh Healthcare Syst, Ctr Hlth Equ Res & Promot,Dept Med, Pittsburgh, PA 15240 USA
[2] Univ Iowa, Sch Publ Hlth, Dept Epidemiol, Iowa City, IA USA
[3] Univ Iowa Hosp & Clin, Dept Internal Med, Iowa City, IA 52242 USA
关键词
hepatitis C; social support; depression; anxiety; quality of life; stigmatization;
D O I
10.3748/wjg.v12.i27.4665
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To systematically examine the impact of the hepatitis C virus (HCV) diagnosis on patients' level of social support in a large-scale study. METHODS: Patients evaluated and treated for HCV in a tertiary referral center were enrolled in a cross-sectional study. Demographic data, functional and emotional status as measured by the Hospital Anxiety and Depression Scale (HAD) and the Sickness Impact Profile (SIP), severity of liver disease, mode of acquisition, and physical and psychiatric comorbidities were collected from patients or abstracted from the medical record. All participants completed a semi-structured interview, addressing questions of social support. RESULTS: A total of 342 patients (mean age 45.2 years; 37% women) were enrolled. Ninety-two (27%) patients described lower levels of support by family and friends. Nearly half of the participants (45%) noted the loss of at least one relationship due to the disease. Fears related to transmitting the disease (25%) were common and often associated with ignorance or even discrimination by others (19%). Nearly one fifth of the patients did not share information about their disease with others to avoid being stigmatized. Lower levels of social support were significantly associated with living alone, being unemployed, being excluded from antiviral therapy, having psychiatric comorbidities, contracting HCV through intravenous drug use, having high levels of anxiety and depression as measured by the HAD and negative mood state as measured by the SIR Patients reporting lower levels of social support also noted more physical symptoms as measured by the SIP. CONCLUSION: Patients with hepatitis C often face significant social problems, ranging from social isolation to familial stress. The most common concerns reflect a limited insight of patients and their relatives and friends about the disease, the risk factors for its spread, and about potential consequences. Our data suggest that educational interventions targeting support persons and the stressors identified in our findings may lessen or alleviate the social strains patients with hepatitis C experience. (c) 2006 The WJG Press. All rights reserved.
引用
收藏
页码:4665 / 4672
页数:8
相关论文
共 53 条
[1]  
Akobeng A K, 2000, J Pediatr Gastroenterol Nutr, V30, P224, DOI 10.1097/00005176-200002000-00028
[2]  
Banwell Cathy, 2005, Health Care Women Int, V26, P340, DOI 10.1080/07399330590925862
[3]   THE SICKNESS IMPACT PROFILE - DEVELOPMENT AND FINAL REVISION OF A HEALTH-STATUS MEASURE [J].
BERGNER, M ;
BOBBITT, RA ;
CARTER, WB ;
GILSON, BS .
MEDICAL CARE, 1981, 19 (08) :787-805
[4]   Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients [J].
Bernstein, D ;
Kleinman, L ;
Barker, CM ;
Revicki, DA ;
Green, J .
HEPATOLOGY, 2002, 35 (03) :704-708
[5]   Chronic diseases and depression: the modifying role of psychosocial resources [J].
Bisschop, MI ;
Knegsman, DMW ;
Beekman, ATF ;
Deeg, DJH .
SOCIAL SCIENCE & MEDICINE, 2004, 59 (04) :721-733
[6]   Increased depressive ratings in patients with hepatitis C receiving interferon-α-based immunotherapy are related to interferon-α-induced changes in the serotonergic system [J].
Bonaccorso, S ;
Marino, V ;
Puzella, A ;
Pasquini, M ;
Biondi, M ;
Artini, M ;
Almerighi, C ;
Verkerk, R ;
Meltzer, H ;
Maes, M .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2002, 22 (01) :86-90
[7]   Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms [J].
Bonaccorso, S ;
Puzella, A ;
Marino, V ;
Pasquini, M ;
Biondi, M ;
Artini, M ;
Almerighi, C ;
Levrero, M ;
Egyed, B ;
Bosmans, E ;
Meltzer, HY ;
Maes, M .
PSYCHIATRY RESEARCH, 2001, 105 (1-2) :45-55
[8]   Conceptual principles of quality of life: an empirical exploration [J].
Bramston, P ;
Chipuer, H ;
Pretty, G .
JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2005, 49 :728-733
[9]   Quality of life and cost-effectiveness of anti-HCV therapy in HIV-infected patients [J].
Buti, M ;
Wong, J ;
Casado, MA ;
Esteban, R .
JOURNAL OF HEPATOLOGY, 2006, 44 :S60-S64
[10]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383